ESPERVITA THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 13 Jul 2026)
What this means for you
Not registered yet, but its 01 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97818106
- Mark type
- Stylized text
- Filed
- 01 Mar 2023
- Published for opposition
- 16 Jan 2024
- Attorney of record
- Daniel Heaton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic disease and cancer
Owner
- Espervita Therapeutics, Inc., Saline, MI, US
- Espervita Therapeutics, Inc., Saline, MI, US
Prosecution history
- 11 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2026 — SOU EXTENSION 4 GRANTED
- 12 Mar 2026 — SOU EXTENSION 4 FILED
- 13 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Apr 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 17 Apr 2026 — NOTICE OF REVIVAL - E-MAILED
- 17 Apr 2026 — PETITION TO REVIVE-GRANTED
- 17 Apr 2026 — TEAS PETITION TO REVIVE RECEIVED
- 13 Apr 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Apr 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2025 — SOU EXTENSION 3 GRANTED
- 12 Sept 2025 — SOU EXTENSION 3 FILED
- 12 Sept 2025 — SOU TEAS EXTENSION RECEIVED